Aeroports de Paris SA:戦略・SWOT・企業財務分析

◆英語タイトル:Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014696
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月12日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Aeroports de Paris SA – Strategy, SWOT and Corporate Finance Report
Summary

Aeroports de Paris SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Aeroports de Paris (ADP) builds, develops and manages airports in France. The company owns and operates the three airports of the Ile de France (Paris) region: Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. The company’s portfolio of services include air traffic management, intermodal transportation and terminal management, installation of airport infrastructures, customs services and airport security services. In addition, the company provides other non aviation services such as restaurants, parking and telecommunication spaces, retail services, land and commercial real estate property leasing, stopover assistance services and ground handling, cargo and postal services and related services. ADP is headquartered in Paris, France.

Scope

- Detailed information on Aeroports de Paris SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Aeroports de Paris SA in the form of a SWOT analysis
- An in-depth view of the business model of Aeroports de Paris SA including a breakdown and examination of key business segments
- Intelligence on Aeroports de Paris SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Aeroports de Paris SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Aeroports de Paris SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Aeroports de Paris SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Aeroports de Paris SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Aeroports de Paris SA: Company Overview
Aeroports de Paris SA: Overview and Key Facts
Aeroports de Paris SA: Overview
Aeroports de Paris SA: Key Facts
Aeroports de Paris SA: Key Employees
Aeroports de Paris SA: Key Employee Biographies
Aeroports de Paris SA: Major Products and Services
Aeroports de Paris SA: Company History
Aeroports de Paris SA: Locations and Subsidiaries
Aeroports de Paris SA: Key Competitors
Aeroports de Paris SA: Company Analysis
Aeroports de Paris SA: Business Description
Aeroports de Paris SA: SWOT Analysis
Aeroports de Paris SA: SWOT Overview
Aeroports de Paris SA: Strengths
Aeroports de Paris SA: Weaknesses
Aeroports de Paris SA: Opportunities
Aeroports de Paris SA: Threats
Aeroports de Paris SA: Corporate Financial Deals Activity
Aeroports de Paris SA: Financial Deals Overview
Aeroports de Paris SA: Targets and Partners
Aeroports de Paris SA: Top Deals 2013 – 2017YTD*
Aeroports de Paris SA: Partnership
Aeroports de Paris SA: Divestments
Aeroports de Paris SA: Private Equity and Ownership
Aeroports de Paris SA: Recent Developments
Aeroports de Paris SA: News and Events Summary
Aeroports de Paris SA: Business Expansion
Aeroports de Paris SA: Corporate Governance
Aeroports de Paris SA: Financial Deals
Aeroports de Paris SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Aeroports de Paris SA: Key Facts
Table 2: Aeroports de Paris SA: Key Employees
Table 3: Aeroports de Paris SA: Locations and Subsidiaries
Table 4: Aeroports de Paris SA: Key Competitors
Table 5: Aeroports de Paris SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Aeroports de Paris SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Aeroports de Paris SA: Targets and Partners
Table 8: Aeroports de Paris SA: Top Deals 2013 - 2017YTD*
Table 9: Aeroports de Paris SA: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 10: Aeroports de Paris SA: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 11: Aeroports de Paris SA: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 12: Aeroports de Paris SA: Divestments by Geography (2013 - YTD*2017)
Table 13: Aeroports de Paris SA: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 14: Aeroports de Paris SA: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 15: Aeroports de Paris SA: News and Events Summary
Table 16: Aeroports de Paris SA: Business Expansion
Table 17: Aeroports de Paris SA: Corporate Governance
Table 18: Aeroports de Paris SA: Financial Deals
Table 19: Aeroports de Paris SA: Strategy and Operations

★海外企業調査レポート[Aeroports de Paris SA:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adris grupa dd:企業の戦略・SWOT・財務分析
    Adris grupa dd - Strategy, SWOT and Corporate Finance Report Summary Adris grupa dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Navistar International Corporation (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Jubilee Holdings Limited:企業の戦略・SWOT・財務情報
    Jubilee Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Second Cup Ltd.
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PhaseRx Inc (PZRX)-医療機器分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …
  • JSW Steel Ltd:企業の戦略・SWOT・財務情報
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • LifeScan Inc-医療機器分野:企業M&A・提携分析
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Jiangsu Jiuding New Material Co., Ltd. (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co., Ltd. (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Verso Corporation:企業の戦略・SWOT・財務情報
    Verso Corporation - Strategy, SWOT and Corporate Finance Report Summary Verso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mobile Telecommunications Company KSCP (ZAIN):企業の財務・戦略的SWOT分析
    Mobile Telecommunications Company KSCP (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CardioDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • Kimball International, Inc. (KBAL):企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Invectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company provides product pipeline such as INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine UCPVax. It offers products such as a human telomerase peptide-based v …
  • Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatme …
  • Raiffeisen Group:企業の戦略・SWOT・財務情報
    Raiffeisen Group - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆